Clinical Trials on Philadelphia Positive
Total 5864 results
-
Novartis PharmaceuticalsCompletedPhiladelphia Chromosome Positive Chronic Myelogenous LeukemiaGermany, Canada, France, Spain, Italy
-
University of ConnecticutCompletedStudy Using Vaccination With Heat Shock Protein 70 (HSP70) for the Treatment of CML in Chronic PhaseLeukemia,Myeloid, Chronic | Leukemia,Myeloid,Philadelphia-PositiveUnited States
-
Gruppo Italiano Malattie EMatologiche dell'AdultoRecruitingALL, Adult | Philadelphia-Positive ALL | Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)Italy
-
Novartis PharmaceuticalsCompletedPhiladelphia Chromosome Positive CMLUnited States, Germany, Italy, France
-
PETHEMA FoundationTerminatedPhiladelphia Chromosome-negative or BCR-ABL-negative, CD19-positive ALLSpain
-
The First Affiliated Hospital of Soochow UniversityNot yet recruitingPhiladelphia-Positive ALLChina
-
OHSU Knight Cancer InstituteAriad PharmaceuticalsNo longer availableChronic Myeloid Leukemia | Philadelphia Chromosome Positive (Ph+) LeukemiasUnited States
-
Bristol-Myers SquibbCompletedChronic Myeloid Leukemia | Philadelphia-Positive Myeloid LeukemiaBelgium, Netherlands, Spain, United States, Italy, Canada, France, Germany, Peru, Singapore, United Kingdom, Australia, Sweden, Finland, Israel, Ireland, Denmark, Korea, Republic of, Norway, Austria, South Africa, Switzerland
-
Bristol-Myers SquibbCompletedChronic Myeloid Leukemia | Philadelphia-Positive Myeloid LeukemiaBelgium, Spain, United States, Italy, Argentina, Brazil, Canada, Germany, Peru, Puerto Rico, Singapore, South Africa, Taiwan, United Kingdom, Australia, France, Philippines, Sweden, Thailand, Russian Federation, China, Poland, Finland, Isra... and more
-
Centre Leon BerardActive, not recruitingPhiladelphia Chromosome Positive CML | BCR-ABL Positive Chronic Myelogenous LeukemiaFrance
-
Chen SuningNot yet recruiting
-
The University of Hong KongUnknownChronic Myeloid Leukemia | Philadelphia Chromosome Positive CMLHong Kong
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous LeukemiaUnited States
-
Rambam Health Care CampusMiltenyi Biomedicine GmbHUnknownPhiladelphia Chromosome-positive Chronic Myelocytic LeukemiaIsrael
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedMinimal Residual Disease | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 Positive in RemissionUnited States
-
Hikma Pharmaceuticals LLCCompletedPhiladelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic PhaseEgypt
-
Assiut UniversityNot yet recruitingPossibility of Using microRNA30a as a Prognostic Marker in Philadelphia Positive Leukemic Patients by Measure Level of microRNA30a in Blood Sample
-
Novartis PharmaceuticalsRecruitingMyeloid Leukemia, Philadelphia PositiveKorea, Republic of, Germany, France, United States, Greece, Hungary, Italy, Japan, Poland, Russian Federation, Thailand, Turkey, China, Netherlands
-
Renato MelaragnoUnknownChronic Myeloid Leukemia (CML) With Philadelphia Chromosome-positive (Ph+)Brazil
-
Bristol-Myers SquibbCompletedMyeloid Leukemia, ChronicJapan
-
Merck Sharp & Dohme LLCTerminatedBlast Phase Philadelphia Chromosomes Positive (Ph+) Chronic Myelogenous Leukemia (CML) | Philadelphia Chromosome Positive (Ph+) Acute Lymphocytic Leukemia (ALL)
-
Sheba Medical CenterUnknownLeukemia, Myeloid, Philadelphia-PositiveIsrael
-
Novartis PharmaceuticalsNot yet recruitingPhiladelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase
-
Novartis PharmaceuticalsActive, not recruitingChronic Myeloid Leukemia (CML) Philadelphia Chromosome PositiveUnited States, China, Hungary, Japan, Belgium, Germany, Canada, Singapore, Australia, Israel, Netherlands, Spain, Italy, Korea, Republic of, Bulgaria, France, United Kingdom, Czechia, Sweden, India, Malaysia, Denmark, Taiwan, Norway, Fi... and more
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingChronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous LeukemiaUnited States
-
Novartis PharmaceuticalsCompletedPhiladelphia Chromosome Positive | Chronic Myelogenous Leukemia in Chronic PhaseJapan
-
PfizerCompletedPhiladelphia Chromosome Positive (Ph+) Chronic Myeloid Leukemia (CML)Singapore
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingChronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous LeukemiaUnited States
-
Bristol-Myers SquibbCompletedChronic Myeloid Leukemia | Leukemia, Lymphoblastic, Acute, Philadelphia-positiveNetherlands, United States, Italy, Argentina, Austria, Brazil, Canada, Germany, Peru, United Kingdom, France, Korea, Republic of, Sweden, Finland, Australia, Israel, Belgium, Denmark, Norway, Switzerland
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingPhiladelphia Chromosome Positive | Recurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia | CD19 PositiveUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingPhiladelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Astex Pharmaceuticals, Inc.RecruitingChronic Phase Chronic Myelogenous Leukemia | Philadelphia Chromosome Positive | BCR-ABL1 Positive Chronic Myelogenous Leukemia | BCR-ABL1 PositiveUnited States
-
Novartis PharmaceuticalsCompletedPhiladelphia Chromosome Positive (PH+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)Germany, Belgium, France, Italy, Spain, Hungary, Austria, Sweden, Bulgaria, Denmark, Greece, Slovenia, United Kingdom, Czechia, Romania, Serbia, Slovakia, Portugal, Finland, Norway, Poland
-
Novartis PharmaceuticalsRecruitingPhiladelphia Chromosome-Positive Chronic Myeloid LeukemiaSingapore, France, Germany, United Arab Emirates, Greece, Italy, Czechia, Hungary, United States, India, Oman, Malaysia, Korea, Republic of, Turkey, Bulgaria, Canada, Slovakia, United Kingdom, Argentina, Jordan, Romania, South Africa and more
-
Crystal Mackall, MDCalifornia Institute for Regenerative Medicine (CIRM)Active, not recruitingB Acute Lymphoblastic Leukemia | Philadelphia Chromosome Positive | Minimal Residual Disease | CD19 PositiveUnited States
-
M.D. Anderson Cancer CenterSchering-PloughTerminatedLeukemia, Myeloid, Philadelphia-PositiveUnited States
-
Gruppo Italiano Malattie EMatologiche dell'AdultoTerminatedChronic Myeloid Leukemia | Philadelphia PositiveItaly
-
Novartis PharmaceuticalsTerminatedCML | Philadelphia Chromosome Positive (Ph+) | Chronic Myelogenous Leukemia Chronic Phase(CML-CP) Patients With Low Imatinib Trough LevelsUnited States
-
Gruppo Italiano Malattie EMatologiche dell'AdultoActive, not recruitingChronic Phase Philadelphia Positive | BCR-ABL Positive | Chronic Myeloid LeukaemiaItaly
-
Incyte CorporationCompletedAcute Lymphoblastic Leukemia | BCR-ABL Positive | Philadelphia PositiveItaly
-
Novartis PharmaceuticalsTerminatedPhiladelphia Positive (Ph+) Chronic Myeloid LeukemiaRussian Federation
-
M.D. Anderson Cancer CenterAscentage Pharma Group Inc.Not yet recruitingAdvanced Chronic Myeloid Leukemia | Philadelphia Chromosome-Positive Acute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsNot yet recruitingAcute Lymphoblastic Leukemia | Philadelphia Chromosome-PositiveUnited States
-
Institute of Hematology & Blood Diseases Hospital...RecruitingPhiladelphia Chromosome Positive Acute Lymphoblastic LeukemiaChina
-
Memorial Sloan Kettering Cancer CenterAmgenActive, not recruitingAcute Lymphoblastic Leukemia | Philadelphia Chromosome-PositiveUnited States
-
Goethe UniversityCompletedPhiladelphia Positive Acute Lymphoblastic LeukemiaGermany
-
TakedaActive, not recruitingPhiladelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)United States, China, Spain, Australia, Canada, Argentina, Korea, Republic of, Brazil, Japan, Italy, Mexico, France, Greece, Poland, Russian Federation, Austria, Taiwan, Bulgaria, Finland, Turkey
-
Korea Otsuka Pharmaceutical Co., Ltd.Active, not recruitingChronic Myeloid Leukemia | Philadelphia Chromosome-positive Acute Lymphoblastic LeukemiaKorea, Republic of
-
Chen SuningRecruitingALL, Adult | Philadelphia-Negative ALLChina
-
Nanfang Hospital, Southern Medical UniversityRecruitingAcute Lymphoblastic Leukemia | Philadelphia Chromosome | Adult ALL | Philadelphia-Positive ALL | IKZF1 Gene MutationChina